Clarivate sale of Life Sciences & Healthcare segment to Altaris
We are advising Clarivate on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
PTC Therapeutics $550 million convertible senior notes offering
We advised the initial purchasers on the offering
TARGAN sale to Merck Animal Health
We are advising TARGAN on the transaction
GSK $10.6 billion acquisition of Nuvalent
We are advising GSK on the transaction
Inventiva $120 million underwritten offering
We advised the underwriters on the offering
Roche acquisition of SAGA Diagnostics
We advised Roche on the transaction
Oruka Therapeutics collaboration with Halozyme
We advised Oruka Therapeutics on the transaction
Purdue Pharma completes chapter 11 restructuring
We advised Purdue in connection with its nearly seven year-long chapter 11 restructuring
GH Research $200 million at-the-market offering
We advised GH Research on the establishment of the at-the-market program
Roche acquisition of PathAI
We are advising Roche on the transaction